Sulfagenix's Series A - II Round

Sulfagenix raised a round of funding on December 27, 2016.

Sulfagenix, Inc., and its wholly owned subsidiary, Sulfagenix Australia Pty. Ltd, are built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for n…

Articles about Sulfagenix's Series A - II Round: